Zydus Wellness Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹651Cr
- +32% YoY
- −24.4% QoQ
- Net profit
- −₹53Cr
- Q2 FY25: ₹21 Cr
- Margin
- 3.54%
- −0.4 pp YoY
- −14.5 pp QoQ
Guidance rank: #23 of 33 in Food Products
See the sector's top 10 — free with your mobile number.
The short version
Zydus Wellness targets double-digit growth over the next 3 to 5 years, driven by multi-category, multichannel, and multi-geography strategies. Zydus Wellness targets achieving a 17%-18% EBITDA margin over the next 2 years through gross margin improvements and operating leverage as scale increases.
From Zydus Wellness Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Zydus Wellness targets double-digit growth over the next 3 to 5 years, driven by multi-category, multichannel, and multi-geography strategies.
- Distribution expansion is a key growth lever, with plans to increase direct reach from 6.2 lakh outlets to 3 million and then 3.5 million outlets.
- The company sees growth opportunities in both legacy and new products like RiteBite and Comfort Click, with efforts to expand in existing and new international markets including the U.S.
- Seasonal brand sales, such as Nycil and Glucon-D, are expected to revive in Q4, contributing to margin improvement and revenue growth.
2 more points from Zydus Wellness Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Zydus Wellness Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is focused on expanding distribution, aiming to increase direct reach from around 6.2 lakh outlets to 3 million, then 3.5 million and beyond.
- Strategic investments include acquisitions like Comfort Click to enter and expand in international markets (Europe and U.S.).
- They are investing in expanding general trade and quick commerce channels domestically.
- There are plans to evaluate and possibly launch new products in the RiteBite portfolio, such as protein powders and fitness SKUs.
2 more points from Zydus Wellness Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Zydus Wellness Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Zydus Wellness Ltd said on order book & pipeline — free account, 30 seconds.
Zydus Wellness Ltd — Quarterly revenue & net profit
Zydus Wellness Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 651 | 493 | +32% | 861 | -24.4% |
| Operating profit (EBITDA) | 23 | 20 | +17.3% | 156 | -85.2% |
| Operating margin | 3.54% | 3.98% | -0.4 pp | 18.07% | -14.5 pp |
| Profit before tax | -51 | 24 | -313.5% | 145 | -134.8% |
| Net profit (PAT) | -53 | 21 | -352.6% | 128 | -141.3% |
| EPS (₹) | -1.66 | 0.66 | -351.5% | 4.02 | -141.3% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Zydus Wellness's management said in earlier quarters
Others in Food Products this season
- Shivashrit Foods (Q2 FY26)
For H1 FY26, revenue from operations was ₹61.18 Cr, up 20% YoY from ₹50.79 Cr in H1 FY25 (Page 4). Key investor presentation takeaways from Shivashrit Foods's Q
- HMA Agro Industries (Q2 FY26)
Half-year revenue increased by 57% YoY, with consolidated EBITDA margin expanding from 1.48% to 6.10%. Key concall takeaways from HMA Agro Industries Ltd's Q2…
- Megastar Foods (Q2 FY26)
9,000 lakhs in Q2FY25, indicating ~53.3% YoY growth (Page 6). Key investor presentation takeaways from Megastar Foods's Q2 FY26 investor presentation — and how
- Dodla Dairy (Q2 FY26)
Value-added product sales (excluding bulk) showing positive momentum with a 22% YoY growth in Q2 FY '26. Key concall takeaways from Dodla Dairy Ltd's Q2 FY26…
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Zydus Wellness Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Zydus Wellness Ltd Q2 FY26 results?
Zydus Wellness targets double-digit growth over the next 3 to 5 years, driven by multi-category, multichannel, and multi-geography strategies. Zydus Wellness targets achieving a 17%-18% EBITDA margin over the next 2 years through gross margin improvements and operating leverage as scale increases.
What is Zydus Wellness Ltd share price analysis?
Zydus Wellness Ltd currently shows a neutral. The stock trades at a P/E of 76.2 with a market cap of ₹16,875 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Zydus Wellness Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
